Investor Relations

Welcome to DASHealth Dx Investor Relations

At DASHealth Dx, we are redefining the future of mobile diagnostics by bringing healthcare directly to patients’ doorsteps. Through cutting-edge technology, nationwide logistics, and a patient-first approach, we are transforming diagnostic healthcare to be more accessible, efficient, and data-driven.

Get Started

Why Our Expertise Sets a New
Standard in Diagnostics

Learn more about our deep experience and why we are positioned to change the way diagnostics are delivered!

Watch NOw

Why Invest in DASHealth Dx?

DASHealth Dx is at the forefront of a healthcare revolution. We leverage real-time provider integration and a seamless digital fulfillment process to eliminate inefficiencies in traditional diagnostic testing. Our mission is to make healthcare as seamless as booking a ride, and our growth trajectory reflects significant market demand for decentralized healthcare solutions.

Investment Highlights

Expanding Market Opportunity—The global mobile diagnostics market is growing rapidly, driven by the adoption of telehealth and the need for accessible healthcare solutions.
Proven Business Model— Dash Health combines the nationwide reach of independent specimen collection and delivery expertise with advanced technology, creating an unrivaled mobile diagnostics platform.
Innovative Technology— A fully digital fulfillment process including order intake, visit scheduling, phlebotomist dispatching, collection monitoring, automated communication, and bar-coded labels.
Strong Leadership Team— Experienced executives from healthcare, technology, and logistics sectors driving sustainable growth.
Strategic Partnerships— Established relationships with healthcare providers, payers, and laboratories to streamline diagnostic workflows.

Get Started

Financial Performance & Growth

Dash Health is committed to transparency and long-term value creation for our investors. Key financial and operational highlights include:

Revenue Growth

Strong year-over-year revenue growth driven by increased adoption of mobile diagnostics.

Nationwide Expansion

Rapidly scaling operations to cover all major metropolitan and underserved rural areas.

Operational Efficiency

A seamless, automated, HIPAA-compliant fulfillment process improves service delivery times and accuracy.

Please visit our investor resources section for access to detailed financial reports and earnings statements.

Strategic Growth Initiatives

We are investing in:

Technology Development

Further enhancing our digital platform for better efficiency and integration with laboratory systems.

Market Expansion

Expanding into new regions and healthcare verticals to increase service accessibility.

Partnerships & Acquisitions

Strengthening relationships with leading healthcare organizations and exploring strategic acquisitions.

Regulatory Compliance & Quality Assurance

Ensuring the highest standards in healthcare service delivery.

Meet Our Leadership

Nathan Cron

President

Pioneer in mobile diagnostics & digital health

Investor Resources

Stay informed with our latest updates:

Press Releases
Financial Reports
Investor Presentations
Contact Investor Relations

For investor inquiries, please contact our Investor Relations team at media@nationalphlebotomy.com.

Book a meeting:

Book A Meeting